Tower Research Capital (TRC)’s Acrivon Therapeutics ACRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.5K | Buy |
|
|||||
|
2025
Q1 | $6.27K | Buy |
|
|||||
|
2024
Q4 | $10.6K | Sell |
|
|||||
|
2024
Q3 | $33.3K | Buy |
|
|||||
|
2024
Q2 | $21.9K | Buy |
|
|||||
|
2024
Q1 | $5.84K | Sell |
|
|||||
|
2023
Q4 | $9.93K | Buy |
|
|||||
|
2023
Q3 | $12K | Buy |
|
|||||
|
2023
Q2 | $9.49K | Sell |
|
|||||
|
2023
Q1 | $14K | Buy |
|
|||||
|
2022
Q4 | $2K | Buy |
|